AMRX
Price
$8.06
Change
+$0.06 (+0.75%)
Updated
Jul 25 closing price
Capitalization
1.87B
9 days until earnings call
CRON
Price
$2.05
Change
-$0.02 (-0.97%)
Updated
Jul 25 closing price
Capitalization
1B
11 days until earnings call
Interact to see
Advertisement

AMRX vs CRON

Header iconAMRX vs CRON Comparison
Open Charts AMRX vs CRONBanner chart's image
Amneal Pharmaceuticals
Price$8.06
Change+$0.06 (+0.75%)
Volume$1.12M
Capitalization1.87B
Cronos Group
Price$2.05
Change-$0.02 (-0.97%)
Volume$1.11M
Capitalization1B
AMRX vs CRON Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. CRON commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and CRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AMRX: $8.06 vs. CRON: $2.05)
Brand notoriety: AMRX and CRON are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 71% vs. CRON: 77%
Market capitalization -- AMRX: $1.87B vs. CRON: $1B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while CRON’s TA Score has 6 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • CRON’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, CRON is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.13% price change this week, while CRON (@Pharmaceuticals: Other) price change was +1.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 05, 2025.

CRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than CRON($1.01B). AMRX YTD gains are higher at: 1.768 vs. CRON (1.485). AMRX has higher annual earnings (EBITDA): 400M vs. CRON (-71.8M). CRON has more cash in the bank: 862M vs. AMRX (91.5M). CRON has less debt than AMRX: CRON (2.55M) vs AMRX (2.75B). AMRX has higher revenues than CRON: AMRX (2.39B) vs CRON (87.2M).
AMRXCRONAMRX / CRON
Capitalization1.87B1.01B186%
EBITDA400M-71.8M-557%
Gain YTD1.7681.485119%
P/E Ratio90.00N/A-
Revenue2.39B87.2M2,745%
Total Cash91.5M862M11%
Total Debt2.75B2.55M107,756%
FUNDAMENTALS RATINGS
AMRX vs CRON: Fundamental Ratings
AMRX
CRON
OUTLOOK RATING
1..100
6974
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
59100
SMR RATING
1..100
9984
PRICE GROWTH RATING
1..100
5651
P/E GROWTH RATING
1..100
2778
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (92) in the Pharmaceuticals Major industry. This means that CRON’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (59) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRON (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than CRON’s over the last 12 months.

CRON's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that CRON’s stock grew similarly to AMRX’s over the last 12 months.

CRON's Price Growth Rating (51) in the Pharmaceuticals Other industry is in the same range as AMRX (56) in the Pharmaceuticals Major industry. This means that CRON’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (27) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRON (78) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than CRON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXCRON
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 6 days ago
69%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLEIX63.671.35
+2.17%
Value Line Small Cap Opportunities Instl
QAACX50.950.29
+0.57%
Federated Hermes MDT All Cap Core A
MUXAX27.750.11
+0.40%
Victory S&P 500 Index A
VRTIX347.261.38
+0.40%
Vanguard Russell 2000 Index I
BFONX21.740.06
+0.28%
Biondo Focus Investor

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.75%
PAHC - AMRX
47%
Loosely correlated
-0.88%
VTRS - AMRX
45%
Loosely correlated
+0.64%
AMPH - AMRX
40%
Loosely correlated
-1.15%
EBS - AMRX
39%
Loosely correlated
-4.02%
ZTS - AMRX
39%
Loosely correlated
-0.46%
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with OGI. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-0.97%
OGI - CRON
59%
Loosely correlated
+1.32%
CGC - CRON
58%
Loosely correlated
+2.70%
TLRY - CRON
58%
Loosely correlated
-2.03%
ACB - CRON
56%
Loosely correlated
+0.62%
AMRX - CRON
31%
Poorly correlated
+0.75%
More